GFA protein reactivity in nerve sheath tumors: a polyvalent and monoclonal antibody study.
We studied glial fibrillary acidic (GFA) protein immunoreactivity in 30 schwannomas, including two intracerebral examples, 26 neurofibromas and 12 neuromas using the immunoperoxidase method with a polyvalent antiserum (PVAS) and three well-characterized monoclonal antibody (MAb) preparations. Twelve of the schwannomas, including both intracerebral tumors, two of the neurofibromas and none of the neuromas immunostained with PVAS. Except for one schwannoma, all the PVAS-positive tumors were positive with two of the MAb preparations. While both of the intracerebral schwannomas were positive with the third MAb, none of the extracerebral tumors were. Our results suggest that: 1) human nerve sheath tumors contain cells having polypeptides that share epitopes with GFA protein, but 2) these polypeptides differ from astrocytic GFA protein by at least one epitope, and 3) the location of the tumors in relation to the central nervous system may influence GFA protein immunoreactivity.
Stanton
C
C
Department of Pathology, University of Virginia School of Medicine, Charlottesville 22908.
Perentes
E
E
Collins
V P
VP
Rubinstein
L J
LJ
D000906:Antibodies / Q000276:immunology*; D000911:Antibodies, Monoclonal; D005904:Glial Fibrillary Acidic Protein / Q000032:analysis*; D006801:Humans; D007124:Immunoenzyme Techniques; D009423:Nervous System Neoplasms / Q000032:analysis* / Q000276:immunology; D009442:Neurilemmoma / Q000032:analysis* / Q000276:immunology; D009455:Neurofibroma / Q000032:analysis* / Q000276:immunology; D009463:Neuroma / Q000032:analysis* / Q000276:immunology
D000906:Antibodies; D000911:Antibodies, Monoclonal; D005904:Glial Fibrillary Acidic Protein